Innovation Today, Healthier Tomorrows
November 4, 2016
Focus on prevention, early diagnosis, and innovative treatment options.
Chronic obstructive pulmonary disease or COPD affects over 24 million Americans and is the third leading cause of death in the United States. Since there remains no cure for COPD, the focus is on prevention, early diagnosis, and innovative treatment options to help patients manage the disease better. Although guidelines for the diagnosis and management of COPD currently exist, many clinicians may not be familiar with them or may not have implemented these guidelines in their practices yet. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) group has developed recommendations for COPD management. Patients and caregiver education is also a crucial part of a successful COPD treatment plan. Lifestyle changes, keeping up with changing symptoms and disease progression must be communicated effectively to the patient’s physician for successful symptom management. It’s also important for patients to be proactive when exacerbation occurs by keeping track and following up with their doctor.
Clinical trials are an opportunity for patients to receive promising new therapies, but they can be difficult to navigate. Learn how The Leukemia & Lymphoma Society’s Clinical Trial Support Center is helping guide patients.
There are approximately 7,000 known rare diseases, but only 5% of them have an approved treatment. Learn how early intervention, proper management strategies, and clinical trials are key for rare disease patients.
Friedreich’s Ataxia is a progressive and debilitating neurological disorder. It's important to recognize symptoms and obtain an early diagnosis to properly manage the condition.